Insulin-Ferein Chr

Insulin-Ferein CR: Russian short-acting insulin

Insulin-Ferein CR, also known as Diarapid CR, is a Russian drug from the group of short-acting insulins. It is produced by the Bryntsalov-A company in Russia. Insulin-Ferein PR is a soluble insulin produced from a human semi-synthetic source.

The main purpose of Insulin-Ferein PR is to treat diabetes. Diabetes is a chronic disease associated with insufficient levels of insulin in the body. Insulin-Ferein PR is used to control blood glucose levels in patients with diabetes mellitus.

Insulin-Ferein PR has two dosage forms: injection solution with a concentration of 100 IU/ml and injection solution with a concentration of 40 IU/ml. This means that the drug is available in different dosages, allowing you to individualize treatment and achieve maximum blood glucose control.

Due to its short duration of action, Insulin-Ferein PR allows you to quickly reduce glucose levels after meals. This is especially important for patients with diabetes, who have impaired normal blood sugar regulation. In addition, Insulin-Ferein PR can be used in combination with other types of insulin or other drugs to achieve optimal glycemic control.

The manufacturing country, Russia, guarantees that the drug meets high quality and safety standards. The production of Insulin-Ferein CR is carried out in strict accordance with international standards, which ensures the reliability and effectiveness of the drug.

In conclusion, Insulin-Ferein CR is a Russian soluble short-acting insulin intended for the control of blood glucose levels in patients with diabetes. It is highly effective and safe, making it an indispensable tool in the treatment of this chronic disease.